Clinical Trial: Breast Cancer Organelle Properties and Protein Expression Atlas in the Three Immunohistochemical Subtypes of Breast Cancers

U.S., Nov. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07233928) titled 'Breast Cancer Organelle Properties and Protein Expression Atlas in the Three Immunohistochemical Subtypes of Breast Cancers' on Nov. 14.

Brief Summary: This trial is a translational, open-label, monocentric and prospective cohort study of participants with breast cancer aiming to create a combined ESPRESSO (= organelle properties) phenotype and spatial proteomics data collection encompassing four cohorts:

* TN eBC = cohort A,

* HER2+ eBC = cohort B,

* Luminal eBC = cohort C,

* dnMBC = cohort D. In total 1050 participants will be enrolled in the study. Laboratory analysis (including ESPRESSO technique) will be conducted on the bi...